Review
doi: 10.1254/fpj.129.375.
[Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution]
[Article in
Japanese]
Affiliations
- PMID: 17507775
- DOI: 10.1254/fpj.129.375
Item in Clipboard
Review
[Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution]
[Article in
Japanese]
Nihon Yakurigaku Zasshi.
2007 May.
No abstract available
Similar articles
-
Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.Ophthalmology. 2005 Nov;112(11):1992-6. doi: 10.1016/j.ophtha.2005.06.017. Epub 2005 Sep 23. Ophthalmology. 2005. PMID: 16183125 Clinical Trial.
-
Efficacy of fluoroquinolones against pathogenic oral bacteria.Mini Rev Med Chem. 2009 Sep;9(10):1147-58. doi: 10.2174/138955709789055243. Mini Rev Med Chem. 2009. PMID: 19534690 Review.
-
Evidence-based review of moxifloxacin.Int Ophthalmol Clin. 2006 Fall;46(4):61-72. doi: 10.1097/01.iio.0000212139.62428.e6. Int Ophthalmol Clin. 2006. PMID: 17060792 Review. No abstract available.
-
[Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases].Antibiot Khimioter. 2005;50(2-3):64-72. Antibiot Khimioter. 2005. PMID: 16308942 Review. Russian. No abstract available.
-
Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.J Cataract Refract Surg. 2007 Oct;33(10):1790-800. doi: 10.1016/j.jcrs.2007.06.026. J Cataract Refract Surg. 2007. PMID: 17889778 Review.
